{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:46:02Z","timestamp":1793907962471,"version":"4.8.0"},"reference-count":16,"publisher":"Informa UK Limited","issue":"24","funder":[{"name":"Pharmaceutical Product Development (PPD), a part of Thermo Fisher Scientific"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2025,12,17]]},"DOI":"10.1080\/17576180.2025.2608563","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:16:10Z","timestamp":1767618970000},"page":"1731-1745","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Mitigating ADA matrix interferences: semiquantitative double immunoprecipitation for anti-bevacizumab antibody in plasma"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7174-8639","authenticated-orcid":false,"given":"Yu Gus","family":"Hui","sequence":"first","affiliation":[{"name":"PPD Laboratory Services (a Part of Thermo Fisher Scientific)","place":["Henrico, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"PPD Laboratory Services (a Part of Thermo Fisher Scientific)","place":["Henrico, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[{"name":"PPD Laboratory Services (a Part of Thermo Fisher Scientific)","place":["Henrico, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmalyn","family":"Dupree","sequence":"additional","affiliation":[{"name":"PPD Laboratory Services (a Part of Thermo Fisher Scientific)","place":["Henrico, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8722-5410","authenticated-orcid":false,"given":"M. Shane","family":"Woolf","sequence":"additional","affiliation":[{"name":"PPD Laboratory Services (a Part of Thermo Fisher Scientific)","place":["Henrico, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Shah","sequence":"additional","affiliation":[{"name":"PPD Laboratory Services (a Part of Thermo Fisher Scientific)","place":["Henrico, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-1296","authenticated-orcid":false,"given":"Moucun","family":"Yuan","sequence":"additional","affiliation":[{"name":"PPD Laboratory Services (a Part of Thermo Fisher Scientific)","place":["Henrico, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7512-2131","authenticated-orcid":false,"given":"William R.","family":"Mylott","sequence":"additional","affiliation":[{"name":"PPD Laboratory Services (a Part of Thermo Fisher Scientific)","place":["Henrico, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"e_1_3_11_3_1","volume-title":"Developing and validating assays for anti-drug antibody detection guidance for industry","author":"Immunogenicity Testing of Therapeutic Protein Products","year":"2019","unstructured":"Immunogenicity Testing of Therapeutic Protein Products. Developing and validating assays for anti-drug antibody detection guidance for industry. Silver Spring (MD): U.S. Department of Health and Human Services Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CBER); 2019."},{"key":"e_1_3_11_4_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2017-4974"},{"key":"e_1_3_11_5_1","doi-asserted-by":"publisher","DOI":"10.17145\/jab.18.011"},{"key":"e_1_3_11_6_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac5001465"},{"key":"e_1_3_11_7_1","doi-asserted-by":"publisher","DOI":"10.17145\/jab.16.016"},{"key":"e_1_3_11_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac8005439"},{"key":"e_1_3_11_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7682472"},{"key":"e_1_3_11_10_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00538-w"},{"key":"e_1_3_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2007.00800.x"},{"key":"e_1_3_11_12_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3072586"},{"key":"e_1_3_11_13_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-021-00649-y"},{"key":"e_1_3_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2024.113657"},{"key":"e_1_3_11_15_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2017-4973"},{"key":"e_1_3_11_16_1","first-page":"Day3","article-title":"Identification of surrogate peptides of rabbit IgG, IgM and IgA for anti-drug antibody (ADA) isotyping and evaluation of direct and indirect immunoprecipitation strategies towards ADA semi-quantitation by hybrid LC\/MS\/MS","author":"Yu Hui MY","year":"2024","unstructured":"Yu Hui MY, Kumar Shah M, Shane W. Identification of surrogate peptides of rabbit IgG, IgM and IgA for anti-drug antibody (ADA) isotyping and evaluation of direct and indirect immunoprecipitation strategies towards ADA semi-quantitation by hybrid LC\/MS\/MS. WRIB. 2024:Day3\u2013P03.","journal-title":"WRIB"},{"key":"e_1_3_11_17_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9685-5"},{"key":"e_1_3_11_18_1","volume-title":"M10 bioanalytical method validation and study sample analysis","year":"2019","unstructured":"M10 bioanalytical method validation and study sample analysis. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER); 2019."}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2025.2608563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:19:59Z","timestamp":1772763599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17576180.2025.2608563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":16,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025,12,17]]}},"alternative-id":["10.1080\/17576180.2025.2608563"],"URL":"https:\/\/doi.org\/10.1080\/17576180.2025.2608563","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}